Panceagen
Also known as: Pancreas Bioregulator
Panceagen is a pancreatic bioregulator peptide derived from bovine pancreatic tissue that supports pancreatic function and glucose metabolism through tissue-specific regulatory mechanisms.
Panceagen is a 1000-10000 Da research peptide. Panceagen is a pancreatic bioregulator peptide derived from bovine pancreatic tissue that supports pancreatic function and glucose metabolism through tissue-specific regulatory mechanisms.
Also called: Pancreas Bioregulator
1000-10000
Molecular Weight
Daltons
0
Strong Evidence
benefits
3
Studies Cited
peer-reviewed
10-20
Typical Dose
mg
Overview
Panceagen represents a specialized bioregulator peptide extracted from pancreatic tissue, designed to support optimal pancreatic function and metabolic health. This peptide complex works through targeted cellular communication pathways to maintain pancreatic cell integrity and promote healthy insulin production. Research indicates that Panceagen may help restore pancreatic beta-cell function, improve glucose tolerance, and support overall metabolic balance. As part of the bioregulator peptide family, Panceagen follows the principle that organ-specific peptides can communicate with corresponding tissues to maintain homeostasis and cellular repair processes. The peptide's unique amino acid sequence allows it to interact with pancreatic tissue receptors, potentially supporting regenerative processes and maintaining healthy pancreatic enzyme production.
Key Takeaways: Panceagen
- Research doses typically range from 10 to 20 mg via subcutaneous
- 0 benefits with strong evidence, 2 moderate, 3 preliminary
- Half-life: 2-4 hours
- 3 cited research studies in this guide
Mechanism of Action
Panceagen functions through tissue-specific bioregulatory pathways that target pancreatic cells. The peptide complex binds to specific receptors on pancreatic beta-cells and acinar cells, triggering intracellular signaling cascades that promote cellular repair and regeneration. It modulates gene expression related to insulin synthesis and secretion, while supporting pancreatic enzyme production. The bioregulator also influences pancreatic stem cell differentiation and proliferation, potentially helping restore damaged pancreatic tissue. Additionally, Panceagen may enhance antioxidant enzyme activity within pancreatic cells, protecting against oxidative stress that commonly damages pancreatic function.
Research Benefits
Panceagen at a Glance
Panceagen functions through tissue-specific bioregulatory pathways that target pancreatic cells.
Pancreatic Beta-Cell Support
Moderate EvidencePromotes healthy insulin-producing beta-cell function and may help protect against beta-cell apoptosis through anti-apoptotic signaling pathways.
Glucose Metabolism Enhancement
Moderate EvidenceSupports improved glucose tolerance and insulin sensitivity by optimizing pancreatic hormone production and cellular glucose uptake mechanisms.
Digestive Enzyme Production
PreliminaryMaintains healthy production of pancreatic enzymes including amylase, lipase, and protease, supporting optimal digestive function.
Pancreatic Tissue Regeneration
PreliminaryStimulates pancreatic stem cell activity and cellular repair processes, potentially helping restore damaged pancreatic tissue architecture.
Antioxidant Protection
PreliminaryEnhances cellular antioxidant defenses within pancreatic tissue, reducing oxidative stress that contributes to pancreatic dysfunction.
Metabolic Homeostasis
AnecdotalSupports overall metabolic balance through improved pancreatic hormone regulation and enhanced cellular energy metabolism.
Research Dosing Protocols
Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
| Research Protocol | Dose Range | Route |
|---|---|---|
| General pancreatic support | 10–20 mg | subcutaneous |
| Metabolic research | 5–15 mg | oral |
| Beta-cell function studies | 15–30 mg | subcutaneous |
Frequency
Once daily, typically in the evening
Timing
30 minutes before bedtime or 2 hours after last meal
Cycle Length
20 days on, 10 days off
Research Notes
- 1Start with lower doses to assess individual response
- 2Subcutaneous injection preferred for systemic effects
- 3Oral administration may have reduced bioavailability
- 4Monitor glucose levels if diabetic or pre-diabetic
Reconstitution Guide
Standard Reconstitution
Vial Size
20 mg
Bacteriostatic Water
2 mL
Concentration
100 mcg
per 0.1 mL (10 units)
Step-by-Step Guide
Gather Materials
Panceagen vial, bacteriostatic water, alcohol swabs, insulin syringes.
Equilibrate Temperature
Remove the vial from storage and allow it to reach room temperature (5-10 minutes).
Sanitize
Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.
Draw Water
Draw 2 mL of bacteriostatic water into a syringe.
Add Water to Vial
Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.
Mix Gently
Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.
Store Properly
Refrigerate at 2-8°C refrigerated. 30 days after reconstitution.
Storage Temperature
2-8°C refrigerated
Shelf Life
30 days after reconstitution
Important Notes
- •Use bacteriostatic water for injection
- •Inject water slowly down the side of vial
- •Allow to dissolve naturally without shaking
- •Store away from light and heat
- •Do not freeze reconstituted solution
Panceagen Dosing Calculator
Calculate daily intake, cycle totals, and vials needed with pre-filled protocols →
Panceagen Reconstitution Calculator
Calculate concentration, syringe units, and doses per vial with auto-filled values →
Safety & Side Effects
Reported Side Effects
- !Mild injection site irritation or redness
- !Transient hypoglycemia in sensitive individuals
- !Digestive upset or nausea
- !Temporary fatigue or drowsiness
- !Headache during initial use
- !Mild abdominal discomfort
- !Allergic reactions in sensitive individuals
- !Temporary changes in appetite
Potential Interactions
- ⚡Diabetes medications (may enhance hypoglycemic effects)
- ⚡Insulin therapy (requires careful monitoring)
- ⚡Pancreatic enzyme supplements (may have additive effects)
- ⚡Blood glucose-lowering herbs and supplements
Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.
Research Studies
The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.
Bioregulatory peptides in pancreatic function restoration
Study examined the effects of pancreatic bioregulator peptides on beta-cell function and glucose metabolism in laboratory models.
Organ-specific peptides and metabolic regulation
Investigation into tissue-specific bioregulator peptides and their role in maintaining pancreatic homeostasis and metabolic balance.
Peptide bioregulators in diabetes research
Clinical evaluation of bioregulator peptides for supporting pancreatic function and glucose tolerance in metabolic research applications.
Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.
Frequently Asked Questions
Panceagen is a bioregulator peptide that supports natural pancreatic function and insulin production, while insulin is a hormone replacement. Panceagen works to optimize your body's own insulin-producing capacity rather than replacing insulin directly.
Panceagen is used only for research purposes and is not a diabetes treatment. While studies suggest it may support pancreatic beta-cell function, anyone with diabetes should work with healthcare providers for proper medical management.
Research protocols typically use evening dosing, 30 minutes before bedtime or 2 hours after the last meal, to align with natural circadian rhythms of pancreatic function.
Individual responses vary, but research suggests metabolic benefits may become apparent within 2-4 weeks of consistent use, with optimal effects typically observed after 8-12 weeks.
Long-term safety data is limited as this is primarily a research compound. Most protocols use cycling approaches (20 days on, 10 days off) rather than continuous administration.
Panceagen may interact with glucose-lowering supplements and diabetes medications. Research use should involve careful monitoring, especially when combined with other metabolic support compounds.
Subcutaneous injection provides better bioavailability and more predictable blood levels, while oral administration may have reduced absorption but offers convenience for certain research applications.
Yes, both powder and reconstituted Panceagen should be stored refrigerated at 2-8°C. The reconstituted solution remains stable for 30 days when properly stored.
Research & Educational Use Only
All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.